Trends in buprenorphine-waivered providers in Medicaid expansion and non-expansion states by their public listing status.
Sign Up to like & getrecommendations! Published in 2022 at "Substance abuse"
DOI: 10.1080/08897077.2022.2060428
Abstract: Background: The federal government has made several efforts to increase access to buprenorphine for the treatment of opioid use disorder (OUD). However, patients continue to face challenges in access to treatment for OUD. Objectives: This… read more here.
Keywords: non expansion; expansion states; medicaid expansion; waivered providers ... See more keywords